Marko Sysi‐Aho
Impact in
- Biochemistry top 1%
- Lipid metabolism and biosynthesis
- Molecular Biology top 2%
- Metabolomics and Mass Spectrometry Studies
- Sphingolipid Metabolism and Signaling
- Gut microbiota and health
Papers in
-
- Metabolomics and Mass Spectrometry Studies 11
- Sphingolipid Metabolism and Signaling 3
-
- Lipid metabolism and biosynthesis 2
- Co-authors
- Matej Orešič (17 shared papers)Tuulikki Seppänen‐Laakso (9 shared papers)Mikko Katajamaa (2 shared papers)Laxman Yetukuri (4 shared papers)Kim Ekroos (6 shared papers)Reijo Laaksonen (5 shared papers)Dimple Kauhanen (4 shared papers)Hannele Yki‐Järvinen (2 shared papers)
- Journals
- PLoS ONE (4 papers)Atherosclerosis (2 papers)Diabetes (1 paper)Neurocomputing (1 paper)BMC Bioinformatics (1 paper)
- Partner nations
- FinlandGermanyUnited States
In The Last Decade
Marko Sysi‐Aho
31 papers receiving 4.2k citations
Marko Sysi‐Aho's Hit Papers
Peers
Comparison fields: 5 of 143
- Biochemistry 246
- Molecular Biology 2.4k
- Cancer Research 279
- Nutrition and Dietetics 150
- Spectroscopy 170
Countries citing papers authored by Marko Sysi‐Aho
This map shows the geographic impact of Marko Sysi‐Aho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Sysi‐Aho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Sysi‐Aho more than expected).
Fields of papers citing papers by Marko Sysi‐Aho
This network shows the impact of papers produced by Marko Sysi‐Aho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Sysi‐Aho. The network helps show where Marko Sysi‐Aho may publish in the future.
Co-authors
The 25 scholars most cited alongside Marko Sysi‐Aho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol Hit paper breakdown → | 2016 | 546 |
| 2 | 2011 | 456 | |
| 3 | 2008 | 383 | |
| 4 | 2007 | 368 | |
| 5 | 2007 | 297 | |
| 6 | 2016 | 297 | |
| 7 | 2011 | 240 | |
| 8 | 2006 | 197 | |
| 9 | 2015 | 155 | |
| 10 | 2015 | 152 | |
| 11 | 2015 | 144 | |
| 12 | 2011 | 143 | |
| 13 | 2014 | 101 | |
| 14 | 2016 | 93 | |
| 15 | 2009 | 80 | |
| 16 | 2015 | 79 | |
| 17 | 2011 | 77 | |
| 18 | 2013 | 75 | |
| 19 | 2016 | 73 | |
| 20 | 2008 | 55 |
About Marko Sysi‐Aho
Marko Sysi‐Aho is a scholar working on Molecular Biology, Biochemistry, Genetics, Cancer Research and Economics and Econometrics, having authored 32 papers that have together received 4.3k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (11 papers), Lipoproteins and Cardiovascular Health (4 papers), Diabetes and associated disorders (4 papers), Sphingolipid Metabolism and Signaling (3 papers), Complex Systems and Time Series Analysis (3 papers), Evolutionary Game Theory and Cooperation (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Lipid metabolism and biosynthesis (2 papers). The work is most often cited by research in Biochemistry (246 citations), Molecular Biology (2.4k citations), Cancer Research (279 citations), Nutrition and Dietetics (150 citations) and Spectroscopy (170 citations). Marko Sysi‐Aho has collaborated with scholars based in Finland, Germany and United States. Frequent co-authors include Matej Orešič, Tuulikki Seppänen‐Laakso, Mikko Katajamaa, Laxman Yetukuri, Kim Ekroos, Reijo Laaksonen, Dimple Kauhanen, Hannele Yki‐Järvinen, Jaakko A. Kaprio and Kirsi Hannele Pietiläinen. Their work appears in journals such as PLoS ONE, Atherosclerosis, Diabetes, Neurocomputing and BMC Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.